General Catalyst Group Management, LLC

Q2 2026 13F-HR Holdings

Location
Cambridge, MA
Holdings as of
6/30/2026
Date filed
8/14/2026
Form type
13F-HR
Num holdings
14
Total value ($000)
$188,518
Net value change ($000)
+4,955 (2.7%)
New positions
4
Sold out positions
2
Turnover %
76.0%
Sector allocation + QoQ delta (equities-only)
Prev filing: 5/15/2026 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q1 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
Parabilis Medicines, Inc. 43,818 NEW
AVBP 17,444 50.6%
Odyssey Therapeutics, Inc. 15,160 NEW
CART 7,029 26.4%
GUTS 1,644 73.5%
EIKN 754 23.4%
DASH 526 NEW
LIFE 517 62.4%
CVNA 426 NEW
AMZN 387 71.9%
Top Reduces (Value $000, Stocks/ETFs)
IOT -63,380 -100.0%
GTLB -19,939 -100.0%
FIG -45 -14.3%
MAZE -10 -0.0%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type